201/314US=23-A / Câncer
Franklin RB, Costello LC. The role of intermediary metabolism and molecular genetics in prostate cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 397-413. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; METABOLISMO INTERMEDIARIO; GENETICA MOLECULAR; CITRATO; M-ACONITASE; ZINCO; GLUCOSE; ASPARTATO; OXALACETATO; BIOENERGETICOS; LIPOGENESE

202/314US=23-A / Câncer
Ribeiro FR, Skotheim RI, Henrique R, Teixeira MR. Array-based comparative genomic hybridization in prostate cancer: research and clinical applications. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 415-29. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; HIBRIDIZACAO GENOMICA COMPARATIVA

203/314US=23-A / Câncer
Lu S. Prostate cancer: role of Vav3 overexpression in development and progression. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 431-9. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; PROTEINA VAV3

204/314US=23-A / Câncer
Dakubo GD, Parr RL, Jakupciak JP. Prostate cancer: detection and monitoring using mitochondrial mutations as a biomarker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 441-64. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; CANCER DE PROSTATA. DIAGNOSTICO; MUTACAO MITOCONDRIAL; BIOMARCADOR; GENETICA MITOCONDRIAL; BIOENERGETICA MITOCONDRIAL; ONCOLOGIA; METABOLISMO CELULAR; MUTACAO DE DNA

205/314US=23-A / Câncer
El-Sharkawy SL, Abbas NF, El-Hefnawy NG. Prognostic markers in prostatic carcinoma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 465-79. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; MARCADORES PROGNOSTICOS; CARCINOMA DA PROSTATA

206/314US=23-A / Câncer
Schwarzenbach H, Pantel K. Prostate cancer: detection of free tumor-specific DNA in blood and bone marrow. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 481-97. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; DNA; SANGUE; MEDULA OSSEA; GENETICA; EPIGENETICA; CELULAS DE ACIDOS NUCLEICOS; PLASMA; ANALISE DE MICROSSATELITES; POLIMORFISMOS DE UM UNICO NUCLEOTIDEO; PCR BASEADA FLUORESCENCIA

207/314US=23-A / Câncer
Turgut AT, Dogra VS. Prostate carcinoma: evaluation using transrectal sonography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 499-520. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; CARCINOMA DA PROSTATA; ULTRA-SONOGRAFIA TRANSRETAL; DOPPLER COLORIDO; ULTRA-SONOGRAFIA COM CONTRASTE; ELASTOGRAFIA

208/314US=23-A / Câncer
Zanzonico P. Prostate cancer: 16B-[18F] Fluoro-5x-Dihydrotesterone (FDHT) whole-body positron emission tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 521-30. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; 16B-[18F] FLUORO-5X-DIHYDROTESTERONE (FDHT); TOMOGRAFIA POR EMISSAO DE POSITRONS; RECEPTOR DE ANDROGENO

209/314US=23-A / Câncer
Nesslinger NJ, Pai HH, Ludgate CM, Nelson BH. Effects of standard treatments on the immune response to prostate cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 531-55. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; RESPOSTA IMUNOLOGICA

210/314US=23-A / Câncer
Kalakish S, Torti FM. Vinorelbine, Doxorubicin, and Prednisone in hormone refractory prostate cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 557-64. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; VINORELBINA; DOXORUBICINA; PREDNISONA

211/314US=23-A / Câncer
Crook J. Locally advanced protate cancer biochemical recurrence after radiotherapy: use of cyclic androgen withdrawal therapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 565-77. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PROSTATA; RECORRENCIA LOCALMENTE AVANCADO; BIOQUIMICA; RADIOTERAPIA; TERAPIA CICLICA; ANDROGENO

212/314US=23-B / Câncer
Hayat MA. Introduction: gastrointestinal cancer. In: ___. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 3-12. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; TUMORES ESTROMAIS GASTROINTESTINAIS; CANCER GASTRICO; CANCER DE ESOFAGO; CANCER DE PANCREAS

213/314US=23-B / Câncer
Duffour J, Bouché O, Rougier P, Milan C, Bedenne L, Seitz JF, Buecher B, Legoux JL, Ducreux M, Vetter D, Raoul JL, François E, Ychou M. Metastatic gastrointestinal cancer: safety of cisplatin combined with continuous 5-FU and leucovorin (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 13-21. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER GASTROINTESTINAL METASTATICO; CISPLATINA; 5-FU; LEUCOVORINA

214/314US=23-B / Câncer
Imagawa A. Gastrointestinal cancer: endoscopic submucosal dissection (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 23-8. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; DISSECCAO SUBMUCOSA POR VIA ENDOSCOPICA

215/314US=23-B / Câncer
Fujishiro M. Gastrointestinal epithelial neoplasms: endoscopic submucosal dissection (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 29-36. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; NEOPLASIAS GASTROINTESTINAIS EPITELIAIS; DISSECCAO DA SUBMUCOSA POR VIA ENDOSCOPICA

216/314US=23-B / Câncer
Pearlman NW. Inoperable abdomino-pelvic tumors: treatment with radio-frequency ablation and surgical debulking. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 37-41. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; TUMORES &*8203;&*8203;ABDOMINO-PELVICO INOPERAVEIS; ABLACAO POR RADIOFREQUENCIA; CITORREDUCAO CIRURGICA

217/314US=23-B / Câncer
Gotthardt M, Behr TM, Béhé M. Gastrointestinal neuroendocrine tumors: diagnosis using gastrin receptor scintigraphy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 43-52. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; TUMORES GASTROINTESTINAIS NEUROENDOCRINOS; GASTRINA; CINTILOGRAFIA; RADIOPEPTIDE

218/314US=23-B / Câncer
Rubello D, Nanni C. Distal esophagus: evaluation with 18F-FDG PET/CT fusion imaging. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 55-61. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; ESOFAGO DISTAL; 18F-FDG PET/CT; TRANSMISSAO POR EMISSAO DE POSITRONS; TOMOGRAFIA COMPUTADORIZADA; CANCER ESOFAGICO

219/314US=23-B / Câncer
Gill KRS, Woodward TA. Endoscopic ultrasound and staging of esophageal cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 63-75. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER DE ESOFAGO. ESTADIAMENTO; ECOENDOSCOPIA; ASPIRATIVA POR AGULHA FINA; QUIMIORRADIACAO

220/314US=23-B / Câncer
Ishiguro H, Kuwabara Y, Sugito N, Fujii Y. Esophageal cancer: role of RNASEN protein and microRNA in prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 77-81. ISBN 978-1-4020-8899-5.

CANCER; CANCER GASTROINTESTINAL; CANCER DE ESOFAGO; PROTEINA RNASEN; MICRORNA; PROGNOSTICO

Primeira | Anterior | Próxima | Última